Novel [1,2,3]triazolo[1,5-a]pyridine derivatives are trypanocidal by sterol biosynthesis pathway alteration

Author:

Lapier Michel1,Ballesteros-Garrido Rafael2,Guzman-Rivera Daniela1,González-Herrera Fabiola1,Aguilera-Venegas Benjamin3,Moncada-Basualto Mauricio34,Ballesteros Rafael2,Abarca Belén2,Pesce Bárbara1,Kemmerling Ulrike5,Olea-Azar Claudio3,Maya Juan D1

Affiliation:

1. Clinical & Molecular Pharmacology Program, Instituto de Ciencias Biomédicas (ICBM), Facultad de Medicina, Universidad de Chile, Independencia 1027, Santiago, Chile

2. Department of Organic Chemistry, Faculty of Pharmacy, University of Valencia, Avda. Vicent Andrés Estellés s/n 46100 Burjassot, Valencia, Spain

3. Free Radical & Antioxidants Laboratory, Inorganic & Analytical Department, Faculty of Chemical & Pharmaceutical Sciences, Universidad de Chile, Santos Dumont 964, Santiago, Chile

4. Department of Environmental Sciences, Faculty of Chemistry & Biology, Universidad de Santiago de Chile, Chile

5. Anatomy & Developmental Biology Program, Instituto de Ciencias Biomédicas (ICBM), Facultad de Medicina, Universidad de Chile, Independencia 1027, Santiago, Chile

Abstract

Aim: To study a new series of [1,2,3]triazolo[1,5-α]pyridine derivatives as trypanocidal agents because current antichagasic pharmacologic therapy is only partially effective. Materials & methods: The effect of the series upon Trypanosoma cruzi epimastigotes and murine macrophages viability, cell cycle, cell death and on the metabolites of the sterol biosynthesis pathway was measured; also, docking in 14α-demethylase was analyzed. Results: Compound 16 inhibits 14α-demethylase producing an imbalance in the cholesterol/ergosterol synthesis pathway, as suggested by a metabolic control and theoretical docking analysis. Consequently, it prevented cell proliferation, stopping the cellular cycle at the G2/M phase, inducing cell death. Conclusion: Although the exact cell death mechanism remained elusive, this series can be used for the further rational design of novel antiparasitic molecules.

Publisher

Future Science Ltd

Subject

Drug Discovery,Pharmacology,Molecular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3